Glenmede Trust’s Patterson-UTI PTEN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$386K Buy
35,637
+23,755
+200% +$203K ﹤0.01% 1057
2025
Q4
$72.6K Buy
+11,882
New +$70.9K ﹤0.01% 1368
2025
Q1
$412K Buy
+50,070
New +$420K ﹤0.01% 972
2020
Q4
Sell
-3,371
Closed -$9K 1993
2020
Q3
$9K Buy
3,371
+225
+7% +$828 ﹤0.01% 1924
2020
Q2
$10K Buy
3,146
+1,129
+56% +$3.89K ﹤0.01% 1875
2020
Q1
$20K Hold
2,017
﹤0.01% 2103
2019
Q4
$20K Sell
2,017
-52
-3% -$471 ﹤0.01% 2103
2019
Q3
$17 Sell
2,069
-2,794
-57% -$27.4K ﹤0.01% 2128
2019
Q2
$55 Sell
4,863
-443
-8% -$5.7K ﹤0.01% 1635
2019
Q1
$73 Buy
5,306
+467
+10% +$6.12K ﹤0.01% 1518
2018
Q4
$49 Sell
4,839
-5,707
-54% -$84.1K ﹤0.01% 1603
2018
Q3
$180K Sell
10,546
-3,115
-23% -$53.5K ﹤0.01% 1184
2018
Q2
$246K Buy
13,661
+9,646
+240% +$193K ﹤0.01% 1014
2018
Q1
$91K Hold
4,015
﹤0.01% 1427
2017
Q4
$91K Sell
4,015
-161
-4% -$3.34K ﹤0.01% 1427
2017
Q3
$86K Buy
4,176
+389
+10% +$7.17K ﹤0.01% 1460
2017
Q2
$91K Hold
3,787
﹤0.01% 1412
2017
Q1
$91K Buy
3,787
+130
+4% +$3.51K ﹤0.01% 1412
2016
Q4
$97K Buy
3,657
+59
+2% +$1.46K ﹤0.01% 1410
2016
Q3
$80K Sell
3,598
-340
-9% -$6.83K ﹤0.01% 1461
2016
Q2
$83K Buy
3,938
+7
+0.2% +$132 ﹤0.01% 1406
2016
Q1
$69K Sell
3,931
-110
-3% -$1.64K ﹤0.01% 1425
2015
Q4
$60K Sell
4,041
-6,988
-63% -$107K ﹤0.01% 1511
2015
Q3
$144K Buy
11,029
+186
+2% +$2.95K ﹤0.01% 1275
2015
Q2
$203K Sell
10,843
-64,055
-86% -$1.33M ﹤0.01% 1211
2015
Q1
$1.41M Sell
74,898
-56,768
-43% -$973K 0.01% 680
2014
Q4
$2.18M Buy
131,666
+7,176
+6% +$151K 0.02% 552
2014
Q3
$4.05M Buy
124,490
+37,465
+43% +$1.27M 0.04% 427
2014
Q2
$3.04M Buy
87,025
+9,527
+12% +$313K 0.03% 482
2014
Q1
$2.45M Buy
77,498
+39,549
+104% +$1.1M 0.02% 515
2013
Q4
$959K Buy
37,949
+738
+2% +$17.7K 0.01% 684
2013
Q3
$794K Sell
37,211
-25,040
-40% -$514K 0.01% 710
2013
Q2
$1.2M Buy
+62,251
New +$1.36M 0.02% 597

Other funds holding PTEN

Glenmede Trust's PTEN Position: Q1 2026 in Review

Glenmede Trust increased its Patterson-UTI (PTEN) stake by 200% in Q1 2026, buying an estimated $203K and bringing the position to 35,637 shares worth $386K. The position accounts for ﹤0.01% of the portfolio, ranked #1057.

Glenmede Trust first reported a position in PTEN in Q2 2013 and has held it in 33 quarters since. The position peaked at $4.05M in Q3 2014. 410 funds tracked by Wall St. Rank hold PTEN as of Q1 2026.

  • Glenmede Trust held 35,637 shares of Patterson-UTI worth $386K as of Q1 2026.
  • Glenmede Trust bought 23,755 Patterson-UTI shares in Q1 2026, an estimated $203K.
  • Patterson-UTI made up ﹤0.01% of Glenmede Trust's portfolio in Q1 2026, its #1057 holding.
  • Glenmede Trust first reported a position in Patterson-UTI in Q2 2013 and has held it in 33 quarters since.
  • Glenmede Trust's Patterson-UTI position peaked at $4.05M in Q3 2014.
  • 410 funds tracked by Wall St. Rank held Patterson-UTI as of Q1 2026.

Based on Glenmede Trust's 13F filing for Q1 2026, filed 26 May 2026.